πŸ‡ΊπŸ‡Έ FDA
Patent

US 9403802

Heterocyclic compound and use therefor

granted A61PA61P25/04A61P25/18

Quick answer

US patent 9403802 (Heterocyclic compound and use therefor) held by Takeda Pharmaceutical Company Limited expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P25/04, A61P25/18, A61P25/20, A61P25/28